Home/Filings/4/0001567619-22-017101
4//SEC Filing

Moretti August J 4

Accession 0001567619-22-017101

CIK 0001650648other

Filed

Sep 5, 8:00 PM ET

Accepted

Sep 6, 8:41 PM ET

Size

6.3 KB

Accession

0001567619-22-017101

Insider Transaction Report

Form 4
Period: 2022-09-01
Moretti August J
See Remarks
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-09-0160,00060,000 total
    Exercise: $8.04Exp: 2032-08-31Common Stock (60,000 underlying)
Holdings
  • Common Stock

    2,000
Footnotes (1)
  • [F1]The shares underlying the stock option award shall vest and become exercisable as to 1/48th of the underlying shares on each monthly anniversary of September 1, 2022 (the "Vesting Commencement Date") such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, while the grantee remains a service provider to the Company.

Documents

1 file

Issuer

4D Molecular Therapeutics, Inc.

CIK 0001650648

Entity typeother

Related Parties

1
  • filerCIK 0001344412

Filing Metadata

Form type
4
Filed
Sep 5, 8:00 PM ET
Accepted
Sep 6, 8:41 PM ET
Size
6.3 KB